Good morning, everyone, and nice to see you again. Another overcast day here on the Pharmalot corporate campus, where we are, once again, hustling short people off to the local schoolhouse. As you know, this calls for a cup of stimulation or two - our flavor today is pumpkin spice. Please feel free to join us. Meanwhile, here are some tidbits from around your world. Hope your day goes well and do stay in touch...
Bristol Reports Positive Results For Ipilimumab Melanoma Med (Associated Press)
Pfizer Lipitor Subsidy May Hurt Ranbaxy (Bloomberg News)
Cephalon To Acquire Gemin X For $225M (Associated Press)
Many Gastric Banding Patients Have Complications (HealthDay News)
FDA Agrees To Review Shire Angioedema Drug (Pharma Times)